News & Updates from Repair Biotechnologies

Featured Article

Repair Biotechnologies Demonstrates Rapid Reversal of Atherosclerosis in Mouse Models

Featured Article

Repair Biotechnologies Announces 48% Reversal of Atherosclerotic Plaque Lipids in a Preclinical Mouse Study

Featured Article

Repair Biotechnologies Conference Pipeline for Q1 – Q2 2020

Top Reads

Repair Biotechnologies Demonstrates Rapid Reversal of Atherosclerosis in Mouse Models

Repair Biotechnologies Announces 48% Reversal of Atherosclerotic Plaque Lipids in a Preclinical Mouse Study

Repair Biotechnologies Conference Pipeline for Q1 – Q2 2020

Previous

Next

Latest News

Repair Biotechnologies Demonstrates Rapid Reversal of Atherosclerosis in Mouse Models

Repair Biotechnologies Announces 48% Reversal of Atherosclerotic Plaque Lipids in a Preclinical Mouse Study

Repair Biotechnologies Conference Pipeline for Q1 – Q2 2020

Reason to present at the 6th Aging Research for Drug Discovery Forum in Basel

Repair Biotechnologies Raises $2.15M Seed Round to Develop Drugs for Age-Related Diseases

Repair Biotechnologies Closes Pre-Seed Round, Joins Grapeseed.bio Incubator

About

Navigate

Contact

Repair Biotechnologies, Inc.
841 East Fayette St
Syracuse, NY 13210